CEACAM6 and colorectal carcinoma: CEACAM6, sometimes referred to as CD66c, has similar roles, with reports highlighting its role in CRC growth and immunosuppression of T cells; its expression as assessed by IHC in tissue is touted as a poor prognosis marker in CRC[129,131-135].